{"nct_id":"NCT02082639","title":"Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus Vaccine (Cervarix™) When Co-administered With GSK Biologicals' Hepatitis A Vaccine (Havrix®) in Healthy Female Adolescents Aged 9-14 Years","status":"WITHDRAWN","status_verified_date":"2015-07","start_date":"2015-02","start_date_type":null,"primary_completion_date":"2015-08","primary_completion_date_type":"ESTIMATED","completion_date":"2015-11","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["GSK"]}